Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Tokyo - Delayed Quote JPY

Kitanotatsujin Corporation (2930.T)

Compare
149.00
-11.00
(-6.88%)
At close: 3:30:00 PM GMT+9
Loading Chart for 2930.T
  • Previous Close 160.00
  • Open 156.00
  • Bid 149.00 x --
  • Ask 150.00 x --
  • Day's Range 148.00 - 157.00
  • 52 Week Range 136.00 - 207.00
  • Volume 939,000
  • Avg. Volume 730,245
  • Market Cap (intraday) 20.75B
  • Beta (5Y Monthly) 1.44
  • PE Ratio (TTM) 16.59
  • EPS (TTM) 8.98
  • Earnings Date Apr 14, 2025
  • Forward Dividend & Yield 4.40 (2.75%)
  • Ex-Dividend Date Feb 27, 2025
  • 1y Target Est --

Kitanotatsujin Corporation plans, develops, manufactures, and sells health foods, cosmetics, and miscellaneous goods in Japan. It offers health foods and beauty products under the J North Farm brand. The company sell its products through its e-commerce website. Kitanotatsujin Corporation was founded in 2000 and is headquartered in Tokyo, Japan.

www.kitanotatsujin.com

253

Full Time Employees

February 29

Fiscal Year Ends

Recent News: 2930.T

View More

Performance Overview: 2930.T

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

2930.T
0.04%
Nikkei 225 (^N225)
15.33%

1-Year Return

2930.T
23.28%
Nikkei 225 (^N225)
15.07%

3-Year Return

2930.T
35.78%
Nikkei 225 (^N225)
21.79%

5-Year Return

2930.T
65.05%
Nikkei 225 (^N225)
89.56%

Compare To: 2930.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2930.T

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    22.28B

  • Enterprise Value

    17.52B

  • Trailing P/E

    17.82

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.77

  • Price/Book (mrq)

    2.91

  • Enterprise Value/Revenue

    1.39

  • Enterprise Value/EBITDA

    9.28

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.08%

  • Return on Assets (ttm)

    19.50%

  • Return on Equity (ttm)

    25.93%

  • Revenue (ttm)

    9.61B

  • Net Income Avi to Common (ttm)

    1.35B

  • Diluted EPS (ttm)

    8.98

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.36B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    1.47B

Research Analysis: 2930.T

View More

Company Insights: 2930.T

Research Reports: 2930.T

View More

People Also Watch